Research Report

Service: Stock Option Date: 17/09/2025

STOCK INFO
Symbol DIVISLAB
Resistance Level 6117
Support Level 6061
Sample

Stock Open Positive Today

Instrument Type: STOCK OPTION

Recommendation: Buy
Strike Price: 6000 CE
Expiry: 30 SEP 2025
th

Current Market Price: 200

Target Price: 240/280
Stoploss Price: 150

As per our strategy we have marked of Resistance at 6117 and Support at 6061.
Based on the above, Stock was reversal from support level. It has given daily high breakout
.It has given resistance breakout. The chart also maintains a higher top and higher bottom
formation, reinforcing the positive bias. Stock was trading above 200 DMA for buying signal
.As per our analysis, as per the trend we advise buying call option in the mentioned zone.

BUY DIVISLAB 6000 CE ABOVE 200 TARGET 240/280 STOPLOSS 150 -MORNING BELL
RESEARCH

In summary, based on our analysis and prevailing market conditions we have suggested the
above research. It is crucial to implement prudent risk management strategies to navigate
potential market fluctuations.
 Research Report
Service: Stock Option Date: 17/09/2025

STOCK INFO
Symbol NAUKRI
Resistance Level 1388
Support Level 1360
Stock Open Positive Today

Instrument Type: STOCK OPTION

Recommendation: Buy
Strike Price: 1360 CE
Expiry: 30 SEP 2025
th

Current Market Price: 53

Target Price: 65/75
Stoploss Price: 40

As per our strategy we have marked of Resistance at 1388 and Support at 1360.
Based on the above, Stock was reversal from support level. It has given resistance breakout
with huge volume. Stock was trading above 200 DMA for buying signal . It has given
previous session's high breakout, indicating a positive bias going forward. As per the trend
we advise buying call option in the mentioned zone.

BUY NAUKRI 1360 CE ABOVE 53 TARGET 65/75 STOPLOSS 40 -MORNING BELL RESEARCH

In summary, based on our analysis and prevailing market conditions we have suggested the
above research. It is crucial to implement prudent risk management strategies to navigate
potential market fluctuations.
 Research Report

DISCLOSURE:

SEBI Registered Research Analyst Registration No. INH000018850

 Research Analyst Information:

Chetan Sharma Proprietor of Morning Bell Research (hereafter called as “Research Analyst”
or “MORNING BELL RESEARCH”), is a SEBI-registered Research Analyst (Registration No.
INH000018850) under the SEBI (Research Analysts) Regulations, 2014.

 Disciplinary Action:

No penalties / directions have been issued by SEBI under the SEBI Act or Regulations made
there under against MORNING BELL RESEARCH.

 No Financial Interest:

Neither Research Analyst nor its associates, employees or relatives have any financial interest
in any subject company discussed in our research reports.

 No Ownership of Securities:

Neither Research Analyst nor its associates, or relatives hold 1% or more of the securities of
any subject company as of the end of the month immediately preceding the publication of the
research report or the date of any public appearance.

 No Material Conflicts of Interest:

At the time of publication of this research report, Research Analyst and its associates, or
relatives have no material conflict of interest with the subject company.

 No Compensation Received:

1. Neither Research Analyst nor none of our employees and its associates:

 received any compensation from the company which is subject matter of

recommendation/research;
 managed or co-managed the public offering of any company;
 received any compensation for investment banking or merchant banking or
brokerage services from the subject company;
 received any compensation for products or services from the subject company;
 received any compensation or other benefits from the Subject Company or 3rd party
in connection
 served as an officer, director or employee of the subject company;

been engaged in market making activity of the subject company.

 Also, the subject company was not our client during twelve months preceding the date of
report.

 No Third-Party Compensation:

Research Analyst and its associates have not received any compensation or other benefits
from the subject company or any third party in connection with the research report.

 Conflict of interest:
 Research Report
There are no actual or potential conflicts of interest arising from any connection to or
association with any issuer of products/ securities, including any material information or
facts that might compromise its objectivity or independence in the carrying on of Research
Analyst services. Such conflict of interest will be disclosed to the client as and when they
arise.

 Public Appearances:

Research Analyst has not received any compensation from the subject company for any
public appearances within the past 12 months. Additionally, the subject company has not
been a client of Research Analyst during the 12 months preceding the distribution of the
research report.

 General Disclaimer:
Investment in securities markets are subject to market risks. Read all related documents
carefully before investing. The securities mentioned are for illustration purposes only and
should not be considered as a recommendation. MORNING BELL RESEARCH does not
guarantee any returns or performance and disclaims any responsibility for the accuracy or
completeness of the information provided. Registration granted by SEBI, enlistment as RA
with exchange, and certification from NISM do not guarantees the performance of the
intermediary or provide any assurance of returns to investors. These information / opinions
/ views are not meant to serve as a professional investment guide for the readers.

 MORNING BELL RESEARCH owns the website [Link]

("website/ MORNING BELL RESEARCH ").

 MORNING BELL RESEARCH makes research-based recommendations on various

opportunities in the Indian equity market for the short and long term.

 We have never been suspended or barred from doing business by SEBI or any other
authority, nor has SEBI ever cancelled our certificate of registration.

 The firm does not provide merchant banking, investment banking, investment adviser, or
brokerage services.

 The recommendations should not be interpreted as a solicitation of an offer to purchase or

sell any security in a jurisdiction were doing so would be against the law.

 Our subscribers, a third party or anyone else have no rights to forward or share our calls or
SMS or Reports or any information provided by us to/with anyone (through any medium)
which is received directly or indirectly by them. If found so then legal action can be taken.
Please note, any evidence of distribution, unauthorised access, copying, forwarding of
reports/calls will lead to automatic cancellation of subscription without any refunds.

 MORNING BELL RESEARCH disclaims any responsibility for the accuracy, timeliness, or
completeness of information provided on its website, including news, analysis, and pricing.
The company and its affiliates are not liable for decisions made or actions taken based on the
website's content, which is not intended as an offer to buy or sell securities. The website’s
content is protected as intellectual property and cannot be reproduced without permission.
MORNING BELL RESEARCH is not liable for any losses or damages from errors,
inaccuracies, or unauthorized access to its website. Investors should assess all risks before
making any investment decisions, and the company's analysts confirm their
 Research Report
recommendations reflect personal opinions, without influence from the companies they
analyze.

 No part of this content may be copied or transferred in any way without the company's prior
written approval.

Acceptance of this disclosure and disclaimer report is implied by the act of browsing and reading the
content. Strictly Reserved. Registered office of MORNING BELL RESEARCH at 252, Shree Nagar
Extension,Indore, Madhya Pradesh, 452018

Support - Contact us on info@[Link]

CHETAN Digitally
by CHETAN
signed

SHARM SHARMA
Date: 2025.09.17
A [Link] +05'30'